Viewing Study NCT00024557


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2025-12-30 @ 7:18 AM
Study NCT ID: NCT00024557
Status: COMPLETED
Last Update Posted: 2011-06-06
First Post: 2001-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Sponsor: INSYS Therapeutics Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module